2026-10-13 16:55:00 UTC#453896newconfirmednews
SDGR stock news
SDGR stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire11 wire items
2026-10-12 17:51:00 UTC#448151newconfirmednews
BMO Capital maintains Schrödinger at Outperform, raises price target to $30 from $24
2026-09-15 21:02:07 UTC#316934newconfirmednews
Schrödinger (SDGR) shares climb 12% to new 52-week high on AI drug-discovery momentum
2026-09-14 19:19:13 UTC#309586duplicateconfirmednews
Schrödinger (SDGR) reiterates 2028 profitability target and AI-driven product growth strategy
2026-09-14 18:52:33 UTC#309456newconfirmednews
Schrödinger (SDGR) highlights Bunsen and Predictive Tox launches, targets 2028 profitability
2026-09-08 16:01:49 UTC#282147newconfirmednews
Schrödinger's SL-325 DR3 blockade shows durable efficacy; Phase II Crohn's data expected in 2028
2026-08-14 18:20:00 UTC#179620newconfirmednews
UBS Raises Schrödinger (SDGR) Price Target to $19.00 From $13.00
2026-08-06 09:03:04 UTC#135832updateconfirmednews
Schrödinger targets 10%-15% 2026 ACV growth as Bristol-Myers Squibb adopts Bunsen platform
seeking alphaimportance 0.50trust 0.70Schrödinger, Inc. +0.50Bristol-Myers Squibb Company +0.40Bunsen +0.40
2026-08-05 21:48:28 UTC#133181newconfirmednews
Schrödinger, Inc. Q2 2026 adjusted EPS $0.08 beats $0.48 loss estimate; revenue $58.89M beats $47.23M
2026-08-05 13:14:13 UTC#130113newconfirmednews
Schrödinger expands AI drug discovery partnership with Bristol-Myers Squibb
2026-07-22 12:31:00 UTC#62897newconfirmedpress release